Skip to main content

The Role of Interventional Radiology and Image-Guided Ablation in Primary Liver Cancer

  • Chapter
  • First Online:
Liver Cancers
  • 1009 Accesses

Abstract

Percutaneous image-guided ablation is now an established treatment in the control of hepatocellular carcinoma (HCC). While liver transplantation remains the definitive treatment, a lack of donors worldwide excludes this treatment as a realistic possibility for most sufferers. Surgical resection provides the opportunity for cure; however, stringent patient selection criteria employed to avoid complications often means many patients are not eligible for surgery. Thus percutaneous ablation is often an ideal choice for the minimally invasive treatment of early-stage patients who are ineligible for surgery, which can be curative in itself or be utilised as a bridge to future transplantation. With a number of ablation technologies available in the interventional radiologist’s armamentarium, there are few lesions which cannot be treated percutaneously—it is therefore paramount that referral for image-guided ablation is considered in patients who cannot be treated surgically.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci. 2002;963:13–20.

    Article  Google Scholar 

  2. Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB (Oxford). 2005;7(1):42–9.

    Article  Google Scholar 

  3. Nagase N, Yuki H, Hamada T, Hirose S, Kawashima R, Inokuchi K. The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer. 1984;54(7):1461–5.

    Article  Google Scholar 

  4. Llovet JM, Fuster J, Buix J. The Barcelona approach; diagnosis, staging and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10:115–20.

    Article  Google Scholar 

  5. Pompili M, Francica G, Ponziani FR, Iezzi R, Avolio AW. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. World J Gastroenterol. 2013;19(43):7515–30.

    Article  Google Scholar 

  6. Weis S, Franke A, Mössner J, Jakobsen JC, Schoppmeyer K. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. Cochrane Database Syst Rev. 2013;12:CD003046.

    Google Scholar 

  7. Bhatia S, et al. Is antibiotic prophylaxis for percutaneous radiofrequency ablation (RFA) of primary liver tumors necessary? Results from a single-center experience. Cardiovasc Intervent Radiol. 2015;38(4):922–8.

    Article  Google Scholar 

  8. Llovet JM, Vilana R, Brú C, et al. Barcelona Clínic Liver Cancer (BCLC) Group Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33(5):1124–9.

    Article  CAS  Google Scholar 

  9. Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev. 2007;33(5):437–47.

    Article  CAS  Google Scholar 

  10. Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89(10):1206–22.

    Article  CAS  Google Scholar 

  11. Wang T, et al. Microwave ablation of hepatocellular carcinoma as first-line treatment: long term outcomes and prognostic factors in 221 patients. Sci Rep. 2016;6:32728.

    Article  CAS  Google Scholar 

  12. Brace C. Microwave ablation technology: What every user should know. Curr Probl Diagn Radiol. 2009;38(2):61–7.

    Article  Google Scholar 

  13. Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25(Suppl 1):S69–83.

    Article  Google Scholar 

  14. Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee FT Jr. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 2005;236(1):132–9.

    Article  Google Scholar 

  15. Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperth. 2016;32(3):339–44.

    Article  CAS  Google Scholar 

  16. Wang C, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2015;61(5):1579–90.

    Article  Google Scholar 

  17. Rong G, et al. Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria. PLoS One. 2015;10(4):e0123065.

    Article  Google Scholar 

  18. Wu S, Hou J, Ding Y, Wu F, Hu Y, Jiang Q, Mao P, Yang Y. Cryoablation versus radiofrequency ablation for hepatic malignancies. Medicine (Baltimore). 2015;94(49):e2252.

    Article  Google Scholar 

  19. Chakravorty E, et al. Anaesthetic management of radiofrequency tumour ablation: or experience. Indian J Anaesth. 2006;50:123–7.

    Google Scholar 

  20. Wang Y, Luo Q, Li Y, Deng S, Wei S, Li X. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials. PLoS One. 2014;9(1):e84484.

    Article  Google Scholar 

  21. Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107(4):569–77.

    Article  CAS  Google Scholar 

  22. Xu Y, et al. Microwave ablation for the treatment of hepatocellular carcinoma that met up-to-seven criteria: feasibility, local efficacy and long-term outcomes. Eur Radiol. 2017;27(9):3877–87.

    Article  Google Scholar 

  23. Liang P, et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology. 2005;235(1):299–307.

    Article  Google Scholar 

  24. Xu Y, et al. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma. Chin J Cancer. 2017;36(1):14.

    Article  Google Scholar 

  25. Chinnaratha MA, Chuang MY, Fraser RJ, Woodman RJ, Wigg AJ. Percutaneous thermal ablation for primary hepatocellular carcinoma: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(2):294–301.

    Article  Google Scholar 

  26. Sutter O, et al. Safety and efficacy of irreversible electroporation for the treatment of hepatocellular carcinoma not amenable to thermal ablation techniques: a retrospective single-center case series. Radiology. 2017;284(3):877–86.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wong, JJ., Kibriya, N. (2019). The Role of Interventional Radiology and Image-Guided Ablation in Primary Liver Cancer. In: Cross, T., Palmer, D. (eds) Liver Cancers. Springer, Cham. https://doi.org/10.1007/978-3-319-92216-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92216-4_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92215-7

  • Online ISBN: 978-3-319-92216-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics